| Revenue Growth | Total revenue up 13.7% YTD; Direct Patient Services up 27% YTD. |
|---|---|
| Mgmt Confidence | Bullish on Rhode Island and international opportunities despite current debt forbearance. |
| Demand Visibility | Gamma Knife procedures increased 11%; healthy demand across treatment platform. |
| Order Book | Project backlog includes Hospital San Javier Gamma Knife in Guadalajara, Mexico. |
| Margin Trends | Gross margin declined to 18.3% from 20.4% due to cost structure. |
| Op. Leverage | High legal/banking fees currently weighing down profitability and operating margins. |
| Vol vs Price | Gamma Knife volume up 11%; Rhode Island revenue up despite lower volumes. |
| Segment Growth | Direct Patient Services outperforming; Medical Equipment Leasing revenue modestly lower. |
| New Clients | Joint venture with Hospital San Javier in Guadalajara, Mexico. |
| Capex & Debt | $15M debt to Fifth Third Bank; $9.5M cash on hand. |
| Regulatory | Holds CONs for linear accelerator and proton beam in Rhode Island. |
| Commentary | Shifting toward an asset-light model for growth projects like proton beam. |
| New Launches | Upgraded Gamma Knife Esprit in Peru; Guadalajara facility expected mid-2027. |
Growth
Total revenue rose 13.7% to $23.1M; direct patient services grew 27% to $13.5M.
Outlook
Guadalajara facility operational mid-2027; focusing on resolving $15M debt with Fifth Third Bank.
Risks
Management pivoted on Rhode Island efficiency questions, citing 'two steps forward, one step back.'
The company's earnings call, NYSE: AMS, and its 8-K filed with the SEC. Summary written with AI assistance from the call.
Earnings call webcast ↗ Watch on YouTube ↗
American Shared Hospital Services: key numbers
- Share price
- $1.07Close, Nov 16
- Market cap
- $7.14M
- Shares outstanding
- 6.67MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-Medical LaboratoriesSIC 8071
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from American Shared Hospital Services
All →American Shared Hospital Services Q3 2026 Results: Net Loss of $620K, Loss Widens
American Shared Hospital Services reported a net loss of $2,866,000 for the nine months ended September 30, 2026, compared to a loss of $1,719,000 in the prior year period. While total revenues increased to $23,138,000, higher operating costs and selling and administrative expenses led to an increased operating loss of $2,598,000.
- Key figure
- Net loss $620K
American Shared Hospital Services Financial Results
American Shared Hospital Services reported Q3 2026 revenue of $7.6 million, a 6% increase year-over-year, driven by a 14% rise in Direct Patient Services revenue. The company generated $5.8 million in operating cash flow during the first nine months of 2026 and increased its cash position to approximately $9.5 million.
“During the third quarter, we continued to make progress in growing our Direct Patient Services business, with revenue in this segment increasing 14% year over year. For the first nine months of 2026, total revenue increased 14%, driven by continued growth in our Rhode Island radiation therapy operations and higher procedure volumes at our international Gamma Knife facilities.”
Craig Tagawa, Interim Chief Executive Officer
“We continue to focus on positioning the Company for long-term success by building on our established presence in radiation oncology and pursuing opportunities to expand the reach and capabilities of our technology and services.”
Ray Stachowiak, Executive Chairman